Ataxin-3 is a multivalent ligand for the parkin Ubl domain.

PubWeight™: 0.78‹?›

🔗 View Article (PMC 3807529)

Published in Biochemistry on October 09, 2013

Authors

Jane J Bai1, Susan S Safadi, Pascal Mercier, Kathryn R Barber, Gary S Shaw

Author Affiliations

1: Department of Biochemistry, Schulich School of Medicine and Dentistry, University of Western Ontario , London, Ontario, Canada N6A 5C1.

Articles cited by this

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism. Nature (1998) 21.49

Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat Genet (2000) 7.83

Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease. Nat Med (2001) 4.22

A ubiquitin-interacting motif conserved in components of the proteasomal and lysosomal protein degradation systems. Trends Biochem Sci (2001) 3.24

Structure of parkin reveals mechanisms for ubiquitin ligase activation. Science (2013) 2.84

Autoregulation of Parkin activity through its ubiquitin-like domain. EMBO J (2011) 2.75

Synthetic multivalent ligands in the exploration of cell-surface interactions. Curr Opin Chem Biol (2000) 2.57

CHIP is associated with Parkin, a gene responsible for familial Parkinson's disease, and enhances its ubiquitin ligase activity. Mol Cell (2002) 2.53

Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neurons from kainate excitotoxicity. Neuron (2003) 2.49

Solution structure of Vps27 UIM-ubiquitin complex important for endosomal sorting and receptor downregulation. EMBO J (2003) 2.34

Structural studies of the interaction between ubiquitin family proteins and proteasome subunit S5a. Biochemistry (2002) 2.29

Structure and ubiquitin binding of the ubiquitin-interacting motif. J Biol Chem (2003) 2.19

The polyglutamine neurodegenerative protein ataxin-3 binds polyubiquitylated proteins and has ubiquitin protease activity. Hum Mol Genet (2003) 2.13

Structure and function of Parkin E3 ubiquitin ligase reveals aspects of RING and HECT ligases. Nat Commun (2013) 2.10

The deubiquitinating enzyme ataxin-3, a polyglutamine disease protein, edits Lys63 linkages in mixed linkage ubiquitin chains. J Biol Chem (2008) 2.09

PINK1 drives Parkin self-association and HECT-like E3 activity upstream of mitochondrial binding. J Cell Biol (2013) 2.04

Dynamic equilibrium engagement of a polyvalent ligand with a single-site receptor. Proc Natl Acad Sci U S A (2008) 2.00

Ubiquilin interacts with ubiquitylated proteins and proteasome through its ubiquitin-associated and ubiquitin-like domains. FEBS Lett (2004) 1.91

Functional ATPase activity of p97/valosin-containing protein (VCP) is required for the quality control of endoplasmic reticulum in neuronally differentiated mammalian PC12 cells. J Biol Chem (2002) 1.77

Ataxin-3 binds VCP/p97 and regulates retrotranslocation of ERAD substrates. Hum Mol Genet (2006) 1.66

Structural determinants for the binding of ubiquitin-like domains to the proteasome. EMBO J (2003) 1.56

Inactivation of HAUSP in vivo modulates p53 function. Oncogene (2009) 1.48

Poly-ubiquitin binding by the polyglutamine disease protein ataxin-3 links its normal function to protein surveillance pathways. J Biol Chem (2003) 1.44

Structure of the ubiquitin-interacting motif of S5a bound to the ubiquitin-like domain of HR23B. J Biol Chem (2003) 1.40

Ataxin-3, the MJD1 gene product, interacts with the two human homologs of yeast DNA repair protein RAD23, HHR23A and HHR23B. Hum Mol Genet (2000) 1.38

Defining the role of ubiquitin-interacting motifs in the polyglutamine disease protein, ataxin-3. J Biol Chem (2005) 1.34

A disease state mutation unfolds the parkin ubiquitin-like domain. Biochemistry (2007) 1.21

The Machado-Joseph disease-associated mutant form of ataxin-3 regulates parkin ubiquitination and stability. Hum Mol Genet (2010) 1.21

Improvement in the molecular diagnosis of Machado-Joseph disease. Arch Neurol (2001) 1.07

E6-AP promotes misfolded polyglutamine proteins for proteasomal degradation and suppresses polyglutamine protein aggregation and toxicity. J Biol Chem (2008) 0.99

Ataxin-3 deubiquitination is coupled to Parkin ubiquitination via E2 ubiquitin-conjugating enzyme. J Biol Chem (2011) 0.98

Structural transformation of the tandem ubiquitin-interacting motifs in ataxin-3 and their cooperative interactions with ubiquitin chains. PLoS One (2010) 0.92

Familial Parkinson's disease. Alpha-synuclein and parkin. Adv Neurol (2001) 0.92

Splice isoforms of the polyglutamine disease protein ataxin-3 exhibit similar enzymatic yet different aggregation properties. PLoS One (2010) 0.91

Deubiquitinating enzymes: their roles in development, differentiation, and disease. Int Rev Cytol (2003) 0.88

Differential interaction of the E3 ligase parkin with the proteasomal subunit S5a and the endocytic protein Eps15. J Biol Chem (2009) 0.87

Mutant ataxin-3 promotes the autophagic degradation of parkin. Autophagy (2011) 0.84

Mechanism for recognition of polyubiquitin chains: balancing affinity through interplay between multivalent binding and dynamics. J Am Chem Soc (2010) 0.84

Ataxin-3 and its e3 partners: implications for machado-joseph disease. Front Neurol (2013) 0.83

Articles by these authors

Targeted profiling: quantitative analysis of 1H NMR metabolomics data. Anal Chem (2006) 4.36

Autoregulation of Parkin activity through its ubiquitin-like domain. EMBO J (2011) 2.75

Calcium-dependent and -independent interactions of the S100 protein family. Biochem J (2006) 2.62

Identification of a novel Zn2+-binding domain in the autosomal recessive juvenile Parkinson-related E3 ligase parkin. J Biol Chem (2009) 1.98

Structure of the Parkin in-between-ring domain provides insights for E3-ligase dysfunction in autosomal recessive Parkinson's disease. Proc Natl Acad Sci U S A (2007) 1.73

Structural perspective of peptidoglycan biosynthesis and assembly. Annu Rev Biochem (2012) 1.69

A molecular explanation for the recessive nature of parkin-linked Parkinson's disease. Nat Commun (2013) 1.51

Structure of subtilosin A, a cyclic antimicrobial peptide from Bacillus subtilis with unusual sulfur to alpha-carbon cross-links: formation and reduction of alpha-thio-alpha-amino acid derivatives. Biochemistry (2004) 1.50

Metabolite profiling of the intraerythrocytic malaria parasite Plasmodium falciparum by (1)H NMR spectroscopy. NMR Biomed (2009) 1.30

A disease state mutation unfolds the parkin ubiquitin-like domain. Biochemistry (2007) 1.21

In situ orientations of protein domains: troponin C in skeletal muscle fibers. Mol Cell (2003) 1.17

The structure of the UbcH8-ubiquitin complex shows a unique ubiquitin interaction site. Biochemistry (2009) 1.16

Solution structure of the flexible class II ubiquitin-conjugating enzyme Ubc1 provides insights for polyubiquitin chain assembly. J Biol Chem (2004) 1.15

Structure of subtilosin A, an antimicrobial peptide from Bacillus subtilis with unusual posttranslational modifications linking cysteine sulfurs to alpha-carbons of phenylalanine and threonine. J Am Chem Soc (2003) 1.11

Organization of model helical peptides in lipid bilayers: insight into the behavior of single-span protein transmembrane domains. Biophys J (2002) 1.03

Selective recruitment of an E2~ubiquitin complex by an E3 ubiquitin ligase. J Biol Chem (2012) 1.02

Structural insights into the anti-methicillin-resistant Staphylococcus aureus (MRSA) activity of ceftobiprole. J Biol Chem (2012) 1.02

A novel S100 target conformation is revealed by the solution structure of the Ca2+-S100B-TRTK-12 complex. J Biol Chem (2002) 1.01

Ubiquitin manipulation by an E2 conjugating enzyme using a novel covalent intermediate. J Biol Chem (2005) 0.99

Unique S100 target protein interactions. Gen Physiol Biophys (2009) 0.95

Insights into S100 target specificity examined by a new interaction between S100A11 and annexin A2. Biochemistry (2006) 0.93

The dilated cardiomyopathy G159D mutation in cardiac troponin C weakens the anchoring interaction with troponin I. Biochemistry (2008) 0.93

Association of the disordered C-terminus of CDC34 with a catalytically bound ubiquitin. J Mol Biol (2011) 0.92

S100-annexin complexes--structural insights. FEBS J (2008) 0.91

The solution structure of the protein ydhA from Escherichia coli. J Biomol NMR (2006) 0.91

Folding kinetics of the S100A11 protein dimer studied by time-resolved electrospray mass spectrometry and pulsed hydrogen-deuterium exchange. Biochemistry (2006) 0.91

Evidence of a tendency to self-association of the transmembrane domain of ErbB-2 in fluid phospholipid bilayers. Biochemistry (2002) 0.89

NMR solution structure of a highly stable de novo heterodimeric coiled-coil. Biopolymers (2004) 0.89

Systematic analysis of the amino acid residues of human papillomavirus type 16 E7 conserved region 3 involved in dimerization and transformation. J Virol (2011) 0.89

Unmasking the annexin I interaction from the structure of Apo-S100A11. Structure (2003) 0.88

Structure and functional studies of N-terminal Cx43 mutants linked to oculodentodigital dysplasia. Mol Biol Cell (2012) 0.88

Differential interaction of the E3 ligase parkin with the proteasomal subunit S5a and the endocytic protein Eps15. J Biol Chem (2009) 0.87

Conserved region 3 of human papillomavirus 16 E7 contributes to deregulation of the retinoblastoma tumor suppressor. J Virol (2012) 0.87

Impact of autosomal recessive juvenile Parkinson's disease mutations on the structure and interactions of the parkin ubiquitin-like domain. Biochemistry (2011) 0.87

Folding and stability of the b subunit of the F(1)F(0) ATP synthase. Protein Sci (2002) 0.86

Effects of Phe-to-Trp mutation and fluorotryptophan incorporation on the solution structure of cardiac troponin C, and analysis of its suitability as a potential probe for in situ NMR studies. Protein Sci (2005) 0.86

The S100A10-annexin A2 complex provides a novel asymmetric platform for membrane repair. J Biol Chem (2011) 0.86

Interaction of the tail with the catalytic region of a class II E2 conjugating enzyme. J Biomol NMR (2003) 0.85

Design of high-affinity S100-target hybrid proteins. Protein Sci (2009) 0.85

Codon optimization for enhanced Escherichia coli expression of human S100A11 and S100A1 proteins. Protein Expr Purif (2010) 0.85

Is there nascent structure in the intrinsically disordered region of troponin I? Proteins (2011) 0.84

The C-terminus and linker region of S100B exert dual control on protein-protein interactions with TRTK-12. Biochemistry (2002) 0.84

Structure of an asymmetric ternary protein complex provides insight for membrane interaction. Structure (2012) 0.83

Architecture of the catalytic HPN motif is conserved in all E2 conjugating enzymes. Biochem J (2012) 0.83

Solution NMR structure and X-ray absorption analysis of the C-terminal zinc-binding domain of the SecA ATPase. Biochemistry (2004) 0.82

Discovery and characterization of a nonphosphorylated cyclic peptide inhibitor of the peptidylprolyl isomerase, Pin1. J Med Chem (2011) 0.82

Analysis of the structure of human apo-S100B at low temperature indicates a unimodal conformational distribution is adopted by calcium-free S100 proteins. Proteins (2008) 0.81

Characterization of the dehydratase WcbK and the reductase WcaG involved in GDP-6-deoxy-manno-heptose biosynthesis in Campylobacter jejuni. Biochem J (2011) 0.81

Temporal development of protein structure during S100A11 folding and dimerization probed by oxidative labeling and mass spectrometry. J Mol Biol (2011) 0.80

Role of the N-terminal helix I for dimerization and stability of the calcium-binding protein S100B. Biochemistry (2002) 0.80

Structure of the HHARI catalytic domain shows glimpses of a HECT E3 ligase. PLoS One (2013) 0.80

Solution structure of the Escherichia coli protein ydhR: a putative mono-oxygenase. Protein Sci (2005) 0.80

Human S100B protein interacts with the Escherichia coli division protein FtsZ in a calcium-sensitive manner. J Biol Chem (2004) 0.79

Identification of regions responsible for the open conformation of S100A10 using chimaeric S100A11-S100A10 proteins. Biochem J (2011) 0.78

1H, 13C and 15N resonance assignments for the human E2 conjugating enzyme, UbcH7. Biomol NMR Assign (2007) 0.78

Interaction between ErbB-1 and ErbB-2 transmembrane domains in bilayer membranes. FEBS Lett (2002) 0.78

Solution structure of the E3 ligase HOIL-1 Ubl domain. Protein Sci (2012) 0.78

Formation of monomeric S100B and S100A11 proteins at low ionic strength. Biochemistry (2009) 0.78

Identification of calcium-independent and calcium-enhanced binding between S100B and the dopamine D2 receptor. Biochemistry (2011) 0.77

Complete 6-deoxy-D-altro-heptose biosynthesis pathway from Campylobacter jejuni: more complex than anticipated. J Biol Chem (2012) 0.77

Identification of a dimeric intermediate in the unfolding pathway for the calcium-binding protein S100B. J Mol Biol (2008) 0.76

Amide exchange shows calcium-induced conformational changes are transmitted to the dimer interface of S100B. Biochemistry (2007) 0.76

NMR studies of the dynamics of a bifunctional rhodamine probe attached to troponin C. J Am Chem Soc (2008) 0.76

Assignment of 1H, 13C and 15N resonances of human Ca2+-S100B in complex with the TRTK-12 peptide. J Biomol NMR (2002) 0.76

A snapshot of ubiquitin chain elongation: lysine 48-tetra-ubiquitin slows down ubiquitination. J Biol Chem (2014) 0.76

Comparison of predicted epimerases and reductases of the Campylobacter jejuni D-altro- and L-gluco-heptose synthesis pathways. J Biol Chem (2013) 0.75

The effect of the cosolvent trifluoroethanol on a tryptophan side chain orientation in the hydrophobic core of troponin C. Protein Sci (2009) 0.75

1H, 15N and 13C resonance assignments of rabbit apo-S100A11. J Biomol NMR (2002) 0.75

Assignment of the (1)H, (13)C and (15)N resonances of the class II E2 conjugating enzyme, Ubc1. J Biomol NMR (2004) 0.75